Comirnaty® (COVID-19 vaccine, mRNA) – New vaccine approval
August 23, 2021 - The FDA announced the approval of Pfizer/BioNTech’s Comirnaty (COVID-19 vaccine, mRNA), for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.
Top